Investing.com - Autolus Therapeutics reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Autolus Therapeutics announced earnings per share of $-0.470 on revenue of $2.37M. Analysts polled by Investing.com EPS of $-0.471 on revenue of $258.57K.
Autolus Therapeutics 's are down 58% and is trading at $2.345 , still down 70.32% from its 52 week high of $7.90 set on Monday, November 8, 2021.
Autolus Therapeutics follows other major Healthcare sector earnings this month
Autolus Therapeutics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar